Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Roblin

Showing results (151-160 of 252) with videos related to

Pageof 26
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|June 17, 2016
Brief Report: A High Rate of β7+ Gut-Homing Lymphocytes in HIV-Infected Immunological Nonresponders is Associated With Poor CD4 T-Cell Recovery During Suppressive HAARTAlexandre Girard, Delphine Vergnon-Miszczycha, Anne-Emmanuelle Depincé-Berger, et al.
Clinics and Research in Hepatology and Gastroenterology|September 7, 2020
Duration of combination therapy and risk of treatment failure in patients with inflammatory bowel diseaseElsa Lambrescak, Thibaut Vaysse, Matthieu Allez, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 8, 2023
Histological healing induced by tofacitinib in ulcerative colitis: A multicentre studySophie Vieujean, David Laharie, Anthony Buisson, et al.
Journal of Crohn'S & Colitis|June 4, 2018
Soluble Mucosal Addressin Cell Adhesion Molecule 1 and Retinoic Acid are Potential Tools for Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease Treated with Vedolizumab: A Proof of Concept StudyStephane Paul, Nicolas Williet, Thomas Di Bernado, et al.
Inflammatory Bowel Diseases|August 25, 2017
The Association Between Drug Levels and Endoscopic Recurrence in Postoperative Patients with Crohn's Disease Treated with Tumor Necrosis Factor InhibitorsShmuel Fay, Bella Ungar, Stephane Paul, et al.
The American Journal of Gastroenterology|July 27, 2011
Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitisXavier Roblin, Sylvie Pillet, Abderrahim Oussalah, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 23, 2024
Pancreatic steatosis is a strong risk factor for post-ERCP pancreatitis: An emerging conceptCaroline Prouvot, Myriam Boumaiza, Khawla Maoui, et al.
The American Journal of Gastroenterology|August 26, 2010
A multicenter experience with infliximab for ulcerative colitis: outcomes and predictors of response, optimization, colectomy, and hospitalizationAbderrahim Oussalah, Ludovic Evesque, David Laharie, et al.
Annals of Surgical Oncology|January 8, 2016
High Resectability Rate of Initially Unresectable Colorectal Liver Metastases After UGT1A1-Adapted High-Dose Irinotecan Combined with LV5FU2 and Cetuximab: A Multicenter Phase II Study (ERBIFORT)Jean Marc Phelip, Laurent Mineur, Christelle De la Fouchardière, et al.
Journal of Crohn'S & Colitis|October 27, 2022
A Systematic Review on the Interest of Drug-tolerant Assay in the Monitoring of Inflammatory Bowel DiseaseMathilde Barrau, Manon Duprat, Pauline Veyrard, et al.
Pageof 26

Showing results (151-160 of 252) with videos related to

Sort By:
Pageof 26
Journal of Acquired Immune Deficiency Syndromes (1999)|June 17, 2016
Brief Report: A High Rate of β7+ Gut-Homing Lymphocytes in HIV-Infected Immunological Nonresponders is Associated With Poor CD4 T-Cell Recovery During Suppressive HAARTAlexandre Girard, Delphine Vergnon-Miszczycha, Anne-Emmanuelle Depincé-Berger, et al.
Clinics and Research in Hepatology and Gastroenterology|September 7, 2020
Duration of combination therapy and risk of treatment failure in patients with inflammatory bowel diseaseElsa Lambrescak, Thibaut Vaysse, Matthieu Allez, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 8, 2023
Histological healing induced by tofacitinib in ulcerative colitis: A multicentre studySophie Vieujean, David Laharie, Anthony Buisson, et al.
Journal of Crohn'S & Colitis|June 4, 2018
Soluble Mucosal Addressin Cell Adhesion Molecule 1 and Retinoic Acid are Potential Tools for Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease Treated with Vedolizumab: A Proof of Concept StudyStephane Paul, Nicolas Williet, Thomas Di Bernado, et al.
Inflammatory Bowel Diseases|August 25, 2017
The Association Between Drug Levels and Endoscopic Recurrence in Postoperative Patients with Crohn's Disease Treated with Tumor Necrosis Factor InhibitorsShmuel Fay, Bella Ungar, Stephane Paul, et al.
The American Journal of Gastroenterology|July 27, 2011
Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitisXavier Roblin, Sylvie Pillet, Abderrahim Oussalah, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 23, 2024
Pancreatic steatosis is a strong risk factor for post-ERCP pancreatitis: An emerging conceptCaroline Prouvot, Myriam Boumaiza, Khawla Maoui, et al.
The American Journal of Gastroenterology|August 26, 2010
A multicenter experience with infliximab for ulcerative colitis: outcomes and predictors of response, optimization, colectomy, and hospitalizationAbderrahim Oussalah, Ludovic Evesque, David Laharie, et al.
Annals of Surgical Oncology|January 8, 2016
High Resectability Rate of Initially Unresectable Colorectal Liver Metastases After UGT1A1-Adapted High-Dose Irinotecan Combined with LV5FU2 and Cetuximab: A Multicenter Phase II Study (ERBIFORT)Jean Marc Phelip, Laurent Mineur, Christelle De la Fouchardière, et al.
Journal of Crohn'S & Colitis|October 27, 2022
A Systematic Review on the Interest of Drug-tolerant Assay in the Monitoring of Inflammatory Bowel DiseaseMathilde Barrau, Manon Duprat, Pauline Veyrard, et al.
Pageof 26